182 related articles for article (PubMed ID: 24244515)
1. Unbiased proteomics analysis demonstrates significant variability in mucosal immune factor expression depending on the site and method of collection.
Birse KM; Burgener A; Westmacott GR; McCorrister S; Novak RM; Ball TB
PLoS One; 2013; 8(11):e79505. PubMed ID: 24244515
[TBL] [Abstract][Full Text] [Related]
2. Differential profiles of immune mediators and in vitro HIV infectivity between endocervical and vaginal secretions from women with Chlamydia trachomatis infection: a pilot study.
Sperling R; Kraus TA; Ding J; Veretennikova A; Lorde-Rollins E; Singh T; Lo Y; Quayle AJ; Chang TL
J Reprod Immunol; 2013 Sep; 99(1-2):80-7. PubMed ID: 23993451
[TBL] [Abstract][Full Text] [Related]
3. Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.
Dezzutti CS; Hendrix CW; Marrazzo JM; Pan Z; Wang L; Louissaint N; Kalyoussef S; Torres NM; Hladik F; Parikh U; Mellors J; Hillier SL; Herold BC
PLoS One; 2011; 6(8):e23136. PubMed ID: 21858008
[TBL] [Abstract][Full Text] [Related]
4. A High-throughput Bead-based Affinity Assay Enables Analysis of Genital Protein Signatures in Women At Risk of HIV Infection.
Månberg A; Bradley F; Qundos U; Guthrie BL; Birse K; Noël-Romas L; Lindskog C; Bosire R; Kiarie J; Farquhar C; Burgener AD; Nilsson P; Broliden K
Mol Cell Proteomics; 2019 Mar; 18(3):461-476. PubMed ID: 30504243
[TBL] [Abstract][Full Text] [Related]
5. A comparative proteomic analysis of the soluble immune factor environment of rectal and oral mucosa.
Romas LM; Hasselrot K; Aboud LG; Birse KD; Ball TB; Broliden K; Burgener AD
PLoS One; 2014; 9(6):e100820. PubMed ID: 24978053
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive proteomic study identifies serpin and cystatin antiproteases as novel correlates of HIV-1 resistance in the cervicovaginal mucosa of female sex workers.
Burgener A; Rahman S; Ahmad R; Lajoie J; Ramdahin S; Mesa C; Brunet S; Wachihi C; Kimani J; Fowke K; Carr S; Plummer F; Ball TB
J Proteome Res; 2011 Nov; 10(11):5139-49. PubMed ID: 21973077
[TBL] [Abstract][Full Text] [Related]
7. Plasma concentration of injectable contraceptive correlates with reduced cervicovaginal growth factor expression in South African women.
Molatlhegi RP; Liebenberg LJ; Leslie A; Noel-Romas L; Mabhula A; Mchunu N; Perner M; Birse K; Ngcapu S; Adamson JH; Govender K; Garrett NJ; Samsunder N; Burgener AD; Abdool Karim SS; Abdool Karim Q; Passmore JS; McKinnon LR
Mucosal Immunol; 2020 May; 13(3):449-459. PubMed ID: 31896762
[TBL] [Abstract][Full Text] [Related]
8. A systems biology examination of the human female genital tract shows compartmentalization of immune factor expression.
Burgener A; Tjernlund A; Kaldensjo T; Abou M; McCorrister S; Westmacott GR; Mogk K; Ambrose E; Broliden K; Ball B
J Virol; 2013 May; 87(9):5141-50. PubMed ID: 23449785
[TBL] [Abstract][Full Text] [Related]
9. Optimization of the weck-Cel collection method for quantitation of cytokines in mucosal secretions.
Rohan LC; Edwards RP; Kelly LA; Colenello KA; Bowman FP; Crowley-Nowick PA
Clin Diagn Lab Immunol; 2000 Jan; 7(1):45-8. PubMed ID: 10618275
[TBL] [Abstract][Full Text] [Related]
10. Complement-Opsonized HIV Modulates Pathways Involved in Infection of Cervical Mucosal Tissues: A Transcriptomic and Proteomic Study.
Svanberg C; Ellegård R; Crisci E; Khalid M; Borendal Wodlin N; Svenvik M; Nyström S; Birse K; Burgener A; Shankar EM; Larsson M
Front Immunol; 2021; 12():625649. PubMed ID: 34093520
[TBL] [Abstract][Full Text] [Related]
11. Searching for lower female genital tract soluble and cellular biomarkers: defining levels and predictors in a cohort of healthy Caucasian women.
Kyongo JK; Jespers V; Goovaerts O; Michiels J; Menten J; Fichorova RN; Crucitti T; Vanham G; Ariën KK
PLoS One; 2012; 7(8):e43951. PubMed ID: 22952818
[TBL] [Abstract][Full Text] [Related]
12. Randomized Cross-Sectional Study to Compare HIV-1 Specific Antibody and Cytokine Concentrations in Female Genital Secretions Obtained by Menstrual Cup and Cervicovaginal Lavage.
Archary D; Liebenberg LJ; Werner L; Tulsi S; Majola N; Naicker N; Dlamini S; Hope TJ; Samsunder N; Abdool Karim SS; Morris L; Passmore JA; Garrett NJ
PLoS One; 2015; 10(7):e0131906. PubMed ID: 26147923
[TBL] [Abstract][Full Text] [Related]
13. Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women.
Pellett Madan R; Dezzutti CS; Rabe L; Hillier SL; Marrazzo J; McGowan I; Richardson BA; Herold BC;
Am J Reprod Immunol; 2015 Oct; 74(4):323-32. PubMed ID: 26118476
[TBL] [Abstract][Full Text] [Related]
14. The impact of pregnancy on anti-HIV activity of cervicovaginal secretions.
Hughes BL; Dutt R; Raker C; Barthelemy M; Rossoll RM; Ramratnam B; Wira CR; Cu-Uvin S
Am J Obstet Gynecol; 2016 Dec; 215(6):748.e1-748.e12. PubMed ID: 27393267
[TBL] [Abstract][Full Text] [Related]
15. Activation of the Complement System in the Lower Genital Tract During Pregnancy and Delivery.
Livson S; Jarva H; Kalliala I; Lokki AI; Heikkinen-Eloranta J; Nieminen P; Meri S
Front Immunol; 2020; 11():563073. PubMed ID: 33505390
[TBL] [Abstract][Full Text] [Related]
16. Lower genital tract cytokine profiles in South African women living with HIV: influence of mucosal sampling.
Jaumdally SZ; Masson L; Jones HE; Dabee S; Hoover DR; Gamieldien H; Langwenya N; Myer L; Todd CS; Passmore JS
Sci Rep; 2018 Aug; 8(1):12203. PubMed ID: 30111808
[TBL] [Abstract][Full Text] [Related]
17. IL-7-Adjuvanted Vaginal Vaccine Elicits Strong Mucosal Immune Responses in Non-Human Primates.
Logerot S; Figueiredo-Morgado S; Charmeteau-de-Muylder B; Sandouk A; Drillet-Dangeard AS; Bomsel M; Bourgault-Villada I; Couëdel-Courteille A; Cheynier R; Rancez M
Front Immunol; 2021; 12():614115. PubMed ID: 33717097
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of methods for collection and measurement of immunoglobulins in cervical and vaginal secretions of women.
Quesnel A; Cu-Uvin S; Murphy D; Ashley RL; Flanigan T; Neutra MR
J Immunol Methods; 1997 Mar; 202(2):153-61. PubMed ID: 9107304
[TBL] [Abstract][Full Text] [Related]
19. The vaginal microbiome amplifies sex hormone-associated cyclic changes in cervicovaginal inflammation and epithelial barrier disruption.
Bradley F; Birse K; Hasselrot K; Noël-Romas L; Introini A; Wefer H; Seifert M; Engstrand L; Tjernlund A; Broliden K; Burgener AD
Am J Reprod Immunol; 2018 Jul; 80(1):e12863. PubMed ID: 29709092
[TBL] [Abstract][Full Text] [Related]
20. Elafin (SKALP/Trappin-2/proteinase inhibitor-3) is produced by the cervix in pregnancy and cervicovaginal levels are diminished in bacterial vaginosis.
Stock SJ; Duthie L; Tremaine T; Calder AA; Kelly RW; Riley SC
Reprod Sci; 2009 Dec; 16(12):1125-34. PubMed ID: 19723838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
